Amer Renal Assoc Stock Cash Flow From Operations
Amer Renal Assoc fundamentals help investors to digest information that contributes to Amer Renal's financial success or failures. It also enables traders to predict the movement of Amer Stock. The fundamental analysis module provides a way to measure Amer Renal's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Amer Renal stock.
Amer |
Amer Renal Assoc Company Cash Flow From Operations Analysis
Amer Renal's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Amer Renal Cash Flow From Operations | 174.15 M |
Most of Amer Renal's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amer Renal Assoc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
CompetitionIn accordance with the recently published financial statements, Amer Renal Assoc has 174.15 M in Cash Flow From Operations. This is 66.97% lower than that of the Healthcare sector and 24.15% lower than that of the Diagnostics & Research industry. The cash flow from operations for all United States stocks is 82.07% higher than that of the company.
Amer Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amer Renal's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amer Renal could also be used in its relative valuation, which is a method of valuing Amer Renal by comparing valuation metrics of similar companies.Amer Renal is currently under evaluation in cash flow from operations category among related companies.
Amer Fundamentals
| Return On Equity | 17.51 | |||
| Return On Asset | 4.35 | |||
| Profit Margin | (1.11) % | |||
| Operating Margin | 9.73 % | |||
| Current Valuation | 1.26 B | |||
| Shares Outstanding | 34.54 M | |||
| Shares Owned By Insiders | 9.15 % | |||
| Shares Owned By Institutions | 80.77 % | |||
| Number Of Shares Shorted | 608.63 K | |||
| Price To Earning | 144.04 X | |||
| Price To Book | (20.05) X | |||
| Price To Sales | 0.49 X | |||
| Revenue | 814.1 M | |||
| Gross Profit | 254.5 M | |||
| EBITDA | 113.52 M | |||
| Net Income | (16.86 M) | |||
| Cash And Equivalents | 126.9 M | |||
| Cash Per Share | 3.68 X | |||
| Total Debt | 724.51 M | |||
| Debt To Equity | 3.94 % | |||
| Current Ratio | 1.05 X | |||
| Book Value Per Share | (2.33) X | |||
| Cash Flow From Operations | 174.15 M | |||
| Short Ratio | 3.91 X | |||
| Earnings Per Share | (0.52) X | |||
| Price To Earnings To Growth | 2.41 X | |||
| Number Of Employees | 4.98 K | |||
| Beta | 1.11 | |||
| Market Capitalization | 397.94 M | |||
| Total Asset | 938.28 M | |||
| Retained Earnings | (192.31 M) | |||
| Working Capital | 96.27 M | |||
| Current Asset | 193.75 M | |||
| Current Liabilities | 97.47 M |
Pair Trading with Amer Renal
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amer Renal position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amer Renal will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Procter Gamble could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Procter Gamble when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Procter Gamble - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Procter Gamble to buy it.
The correlation of Procter Gamble is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Procter Gamble moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Procter Gamble moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Procter Gamble can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Amer Stock
If you are still planning to invest in Amer Renal Assoc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amer Renal's history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |